Kayo Ichihashi

Improvement of psychiatrists’ clinical knowledge of the treatment guidelines for schizophrenia and major depressive disorders using the ‘Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)’ project: A nationwide dissemination, education, and evaluation study

Yoshikazu Takaesu, Koichiro Watanabe, Shusuke Numata et al. · Psychiatry and Clinical Neurosciences · 2019 · 46 citations · Full text

Prescription patterns in patients with schizophrenia in Japan: First‐quality indicator data from the survey of “Effectiveness of Guidelines for Dissemination and Education in psychiatric treatment (EGUIDE)” project

Kayo Ichihashi, Hikaru Hori, Naomi Hasegawa et al. · Neuropsychopharmacology Reports · 2020 · 43 citations · Full text

Characteristics of discharge prescriptions for patients with schizophrenia or major depressive disorder: Real-world evidence from the Effectiveness of Guidelines for Dissemination and Education (EGUIDE) psychiatric treatment project

Naoki Hashimoto, Norio Yasui‐Furukori, Naomi Hasegawa et al. · Asian Journal of Psychiatry · 2021 · 39 citations · Full text

Hypnotic medication use among inpatients with schizophrenia and major depressive disorder: results of a nationwide study

Ryuji Furihata, Rei Otsuki, Naomi Hasegawa et al. · Sleep Medicine · 2021 · 28 citations

Psychiatry, Psychotropic Medication, Psychopharmacology +8

Clozapine Treatment Is Associated With Higher Prescription Rate of Antipsychotic Monotherapy and Lower Prescription Rate of Other Concomitant Psychotropics: A Real-World Nationwide Study

Shinichiro Ochi, Hiromi Tagata, Naomi Hasegawa et al. · The International Journal of Neuropsychopharmacology · 2022 · 26 citations · Full text